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Évolution de la présentation du cancer  
du sein au cours des dernières décennies
Variations of breast cancer presentations for the last decades
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More progress has been made in the last 30 years in our knowledge of breast cancer than in the previous 1,000. One of the major contributions to this increase of knowledge comes from the so called “St. Gallen guidelines”. 
Every two years, doctors specialising in breast cancer gather in St. Gallen to discuss 
developments and update guidelines on adjuvant therapies. It is always an important 
conference, but its conclusions tend to be measured rather than headline grabbing. 
St. Gallen 2005 signalled that a revolution is underway and that breast cancer treatment 
will never be the same again.
Weighing up the latest evidence, the conference concluded that every breast cancer 
should be characterised according to eight elements: its size, histological type, grading, 
hormone receptor status, lymph node status, proliferation index (Ki 67), cErbB2 status 
and the presence or absence of peritumour vascular invasion. Each of these eight para-
meters of breast cancer is independent of the others, which means breast cancer comes 
in 64 (8 x 8) different variants.
The implications of this are very far reaching. The whole concept of breast cancer as 
a single disease is now dead, and we therefore need to make fundamental changes in 
the way we approach treatment decisions. For a start, the traditional TNM classifica-
tion can no longer be considered and adequate guide to treatment, because it provides 
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information on only two of the eight parameters of significance. The value of cytological 
examination has also been brought into question, because all it can tell us is that we are 
dealing with a breast cancer.
Many treatment dogmas will also need re-examining. For instance, is radiotherapy 
always needed after conservative surgery? What if you have just operated on a 70-year-
old patient, for a very-low-risk tumour – 1 cm in size, no lymph node invasion, grade 
I, 90% oestrogen-receptor positive, 5% Ki 67, no vascular invasion and cErbB2? It may 
take the patient two hours by bus to reach her nearest radiotherapy  centre and another 
two hours home again. Is six weeks of daily radiotherapy really worth the time, energy 
and cost in this case?
Recognising how complex and varied breast cancer is also vindicated the many 
voices who have been calling for breast cancer to be treated in specialist units by teams 
comprising a surgeon, and oncoplastic surgeon, specialised pathologist, radiotherapist, 
medical oncologist and breast care nurse. Given that we now know, it would be utterly 
irresponsible to continue to treat any patient outside of such a specialist setting.
All over Europe, breast units are committed to find new solutions to the arising 
problems (i.e. how to manage properly non palpable lesions, how to reduce the burden 
of radiotherapy without increasing the risk of local recurrence, how to improve the 
cosmetic results of surgery, etc.). 
We need to constantly improve our biological knowledge, our teamwork and our 
communication skills.
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